Cancer

Best Legal Steroids for Muscle Growth, Fat Loss, and Strength: Top Natural Alternatives to Anabolic Steroids For Sale (By CrazyBulk)

Discover the safest, most effective legal steroid alternatives for muscle building, fat loss, and peak strength. Backed by science, CrazyBulk’s…

8 months ago

Best Legal Steroids for Muscle Growth, Fat Loss, and Strength: Top Natural Alternatives to Anabolic Steroids For Sale (By CrazyBulk)

Discover the safest, most effective legal steroid alternatives for muscle building, fat loss, and peak strength. Backed by science, CrazyBulk’s…

8 months ago

The International Myeloma Foundation Mourns the Loss of Board Member and Longtime Philanthropist John O’Dwyer

STUDIO CITY, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the…

8 months ago

The International Myeloma Foundation Mourns the Loss of Board Member and Longtime Philanthropist John O’Dwyer

STUDIO CITY, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the…

8 months ago

Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer

Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025Annamycin is potentially a highly versatile drug capable…

8 months ago

Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer

Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025Annamycin is potentially a highly versatile drug capable…

8 months ago

AP Biosciences Presents Preclinical Data on p95HER/CD137 T-Cell Engager at American Association of Cancer Research Annual Meeting

TAIPEI, Taiwan, April 29, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through…

8 months ago

AP Biosciences Presents Preclinical Data on p95HER/CD137 T-Cell Engager at American Association of Cancer Research Annual Meeting

TAIPEI, Taiwan, April 29, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through…

8 months ago

CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany

Dr. Jacob Lalezari, CEO, and Dr. Richard Pestell, Lead Consultant in Preclinical and Clinical Oncology, to lead CytoDyn group in…

8 months ago

CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany

Dr. Jacob Lalezari, CEO, and Dr. Richard Pestell, Lead Consultant in Preclinical and Clinical Oncology, to lead CytoDyn group in…

8 months ago